Physician profile
Robert Steven Armstrong
NPI 1003058520
$876.16
in general payments reported to CMS, 2019-2025
21 companies · $60.23 in 2025
The $60.23 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $31.90 · 2021: $92.06 · 2022: $150 · 2023: $35.80 · 2024: $175 · 2025: $60.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $155.54 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $140.53 | 2019-2024 | Bridion |
| Medtronic, INC. | $134.61 | 2021-2024 | Progrip |
| Smith+Nephew, INC. | $59.66 | 2019-2022 | |
| Becton, Dickinson and Company | $46.10 | 2025 | Channel Drain |
| Nevro Corp. | $42.45 | 2019 | |
| Abbott Laboratories | $36.51 | 2019 | |
| Covidien LP | $33.36 | 2019 | |
| Integra Lifesciences Corporation | $30.18 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Boston Scientific Corporation | $29.11 | 2019 | |
| Solventum Corporation | $25.85 | 2024 | Activ.A.C. |
| Ethicon US, LLC | $25.25 | 2022 | |
| Braintree Laboratories, INC. | $19.62 | 2024 | Sutab, Suflave |
| Conmed Corporation | $19.41 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $19.16 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $17.89 | 2023 | Rebyota |
| Aroa Biosurgery Incorporated | $14.13 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.10 | 2022 | |
| Kci USA, INC. | $12.70 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.